CVS Health Stock - Morgan Stanley lifts price target after Medicare update

CVS Health stock gets fresh analyst support after recent Medicare developments. Morgan Stanley raises its price target and reiterates an Overweight rating, while investors watch technical levels and sector peers going into the next earnings cycle.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:50 CET. Details in the imprint.

CVS Health Corp. (US1266501006) sits at the intersection of healthcare services and retail pharmacy in the United States. Morgan Stanley recently raised its price target on CVS Health stock and kept an Overweight rating after Medicare-related developments, according to a summary of the Morgan Stanley update.

Morgan Stanley’s latest call

Morgan Stanley recently raised its price target on CVS Health stock to $111 from $106 and reiterated an Overweight rating on the shares after reassessing the company’s Medicare exposure and growth prospects, according to an analyst note summary cited by Intellectia.AI.

The bank’s move comes after earlier concerns about Medicare Advantage reimbursement trends and utilization, an issue that has weighed on sentiment across managed care and diversified healthcare names this year.

How the chart looks now

CBS Health shares recently closed around the high-$90s, with CNBC data showing a last regular-session close near $99.16 on the New York Stock Exchange, followed by modest after-hours trading slightly below that level.

Over the past month, CVS Health stock has gained roughly mid-single digits, with TrendSpider citing a move of about 4.4% over 30 days, suggesting a more constructive trend compared with parts of the health insurance and pharmacy peer group.

What the company sells

CVS Health generates revenue from a combination of retail pharmacy stores under the CVS Pharmacy brand, pharmacy benefit management services through CVS Caremark, and health insurance plans including Medicare and commercial coverage via Aetna.

Where the stock trades today

The shares of CVS Health Corp. (US1266501006) trade on the New York Stock Exchange at $99.16 as of 06/18/2026, 18:04 EDT.

Key facts on CVS Health stock

• Company: CVS Health Corp.
• ISIN: US1266501006
• WKN: 859034
• Ticker: CVS
• Venue: NYSE
• Price (as of 06/18/2026, 18:04 EDT): 99.16 USD
• Market cap: 126,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care / Health Care Providers & Services
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.